Precise diagnosis first
Digital imaging, laboratory work-up and specialist evaluation confirm the exact cause before any treatment is advised.
From Digestion to Motion – We Heal with Precision !!

Assessment and reversal-focused management of fatty liver disease (MASLD/NAFLD), from diagnosis through fibrosis monitoring.
Fatty liver disease is excess fat build-up inside liver cells, most often driven by obesity, insulin resistance, type 2 diabetes or high cholesterol/triglycerides rather than alcohol. In its early stage it is simple and reversible; in a minority of patients it progresses through distinct stages toward permanent liver damage.
Assessment and reversal-focused management of fatty liver disease (MASLD/NAFLD), from diagnosis through fibrosis monitoring.
Fatty liver disease (now more precisely called MASLD — metabolic dysfunction-associated steatotic liver disease, previously known as NAFLD) is a build-up of fat in the liver not caused by heavy alcohol use. It is extremely common, closely linked to obesity, diabetes and high cholesterol, and is usually silent until it has already progressed.
Dr. Neil B. Palkhiwala, Consultant Gastroenterologist and Hepatologist with 12+ years of experience, manages fatty liver disease at Aryav Super Speciality Hospital in Science City, Sola, Ahmedabad, Gujarat — easily reached from Bhadaj, Shilaj, Ghatlodiya, Gota, Thaltej, Hebatpur, Memnagar and Gurukul.
In a minority of patients, fatty liver progresses to inflammation (steatohepatitis) and scarring (fibrosis), which can eventually lead to cirrhosis — which is why early detection and a structured plan matter, even though most patients have no symptoms at all.
Patients choose Dr. Neil B. Palkhiwala for accurate staging of the disease, a realistic weight and metabolic-control plan, and coordinated care with our obesity and nutrition clinic where structured support is needed.
At Aryav Super Speciality Hospital, Sola, Ahmedabad, Gujarat, this treatment is planned and performed by Dr. Neil B. Palkhiwala and the clinical team, supported by advanced imaging, modular operation theatres, dedicated intensive care and an in-house rehabilitation unit.

Blood tests for liver function and metabolic profile (blood sugar, lipids).
Ultrasound to confirm fat in the liver and assess its overall appearance.
Non-invasive fibrosis assessment to check whether scarring has already started.
A structured weight-loss and metabolic-control plan — usually the single most effective treatment.
Coordinated referral to our obesity and nutrition clinic where structured weight management support is needed.

Dr. Neil B. Palkhiwala
Consultant Gastroenterologist & Hepatologist
MBBS, MD, DM, MRCP SCE (UK)
Dr. Neil B. Palkhiwala is a highly qualified and compassionate Consultant Gastroenterologist and Hepatologist, committed to delivering comprehensive digestive and liver care with a patient-first approach. He is the Founder and Director of Aryav Superspeciality Hospital in Ahmedabad, Gujarat.
View full profileDigital imaging, laboratory work-up and specialist evaluation confirm the exact cause before any treatment is advised.
Modern techniques and modular operation theatres help reduce tissue damage, blood loss and hospital stay.
Every option — medical, endoscopic or surgical — is explained with expected outcomes, recovery time and cost.
Physiotherapy, diet guidance and scheduled reviews continue well after discharge.
Dr. Neil B. Palkhiwala, Consultant Gastroenterologist and Hepatologist with over 12 years of experience, personally evaluates and manages every fatty liver patient at Aryav.
In the early stages, yes. Sustained weight reduction of seven to ten percent often reverses fat and inflammation in the liver.
Rarely. Non-invasive fibrosis assessment (blood-based scores and imaging) is sufficient for most patients; a biopsy is reserved for selected unclear cases.
It can be. Fatty liver is usually silent, and a minority of patients progress to inflammation and scarring without ever feeling unwell, which is why screening and follow-up matter even without symptoms.
No. Most patients with simple fatty liver never progress to cirrhosis, especially with early weight and metabolic control. Regular monitoring identifies the minority who need closer follow-up.
Lifestyle change remains the primary treatment for most patients. Medication may be considered in specific situations and is discussed individually based on your stage and risk factors.
Dr. Neil B. Palkhiwala treats fatty liver disease at Aryav Super Speciality Hospital, Science City, Sola, Ahmedabad — convenient for patients from Bhadaj, Shilaj, Ghatlodiya, Gota, Thaltej, Hebatpur, Memnagar and Gurukul.
Speak to our gastroenterology and orthopaedic specialists at Aryav Super Speciality Hospital, Ahmedabad. Same-day consultations available.